InvestorsHub Logo
Followers 3167
Posts 208744
Boards Moderated 2
Alias Born 02/04/2004

Re: mopar44o post# 13137

Thursday, 09/24/2015 2:15:34 PM

Thursday, September 24, 2015 2:15:34 PM

Post# of 38634
The CFO isn't lying...IPCI doesn't control when the FDA grants their decisions. So by Q3 results by/b4 October 15th when earnings hit I fully expect to see updates on Focalin and Rexista bioequivalence so we can better gauge how/when the next steps with the FDA should be forthcoming.

Focalin bioequivalence takes 60 days and Rexista bioequivalence takes 6 months...so updates on progress on both those fronts should be forthcoming in the Q exactly as the CFO told sprot

Love the trend not the stock - If you fail to plan your trades you plan to fail

My posts are just my own opinion!